Zhejiang Ausun Pharmaceutical Co (SHSE:603229) ROCE % : 13.56% (As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhejiang Ausun Pharmaceutical Co's annualized ROCE % for the quarter that ended in Sep. 2023 was 13.56%.

Zhejiang Ausun Pharmaceutical Co ROCE % Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co ROCE % Chart

Zhejiang Ausun Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROCE %

Get a 7-Day Free Trial

8.57

10.02

10.81

13.15

18.20

Zhejiang Ausun Pharmaceutical Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
ROCE %	Get a 7-Day Free Trial															17.32	14.19	23.99	14.16	13.56

Zhejiang Ausun Pharmaceutical Co ROCE % Calculation

Zhejiang Ausun Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2022 )		(A: Dec. 2021 )		(A: Dec. 2022 )
	=	261.966	/	( ( (1839.455 - 530.323)	+	(2315.33 - 745.424) )	/ 2 )
	=	261.966	/	( (1309.132	+	1569.906)	/ 2 )
	=	261.966	/	1439.519
	=	18.20 %

Zhejiang Ausun Pharmaceutical Co's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Jun. 2023 )		(Q: Sep. 2023 )
	=	298.292	/	( ( (3013.264 - 823.659)	+	(2973.291 - 764.684) )	/ 2 )
	=	298.292	/	( ( 2189.605	+	2208.607 )	/ 2 )
	=	298.292	/	2199.106
	=	13.56 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhejiang Ausun Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016

Website

http://www.ausunpharm.com

Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Headlines

No Headlines